Patient-Reported Outcome Instruments Used to Assess Pain and Functioning in Studies of Bisphosphonate Treatment for Bone Metastases
-
2012/04/01
-
Details
-
Personal Author:
-
Description:Purpose: When treating metastatic bone disease, relief of bone pain is often a key outcome. Because pain cannot be quantified with objective clinical measures, patient-reported outcome (PRO) measures are required to assess patients' subjective experience. The goal of the current review was to examine measures used to assess pain, as well as the impact of pain on functional status and health-related quality of life (HRQL), in trials of bisphosphonates for the treatment of bone metastases. Methods: A literature search focused on articles published from January 1999 to April 2009. Results: A total of 49 articles were located that used PROs to assess pain-related outcomes of bisphosphonate treatment for bone metastases. The Brief Pain Inventory was the most commonly used multi-item instrument. However, the most common approach for assessing pain was to administer a single-item scale such as a visual analog scale, numerical rating scale, or verbal rating scale. Of the 49 studies, 19 included a PRO assessing functional status or HRQL. Conclusions: Although pain is an important outcome of trials examining treatment for bone metastases, the current review suggests that there is little consistency in PRO measurement across studies. Furthermore, presentation of measures often lacked clear description, information on measurement properties, citations, clarity regarding method of administration, and consistent instrument names. Recommendations are provided for instrument validation within the target population, assessment of content validity, use of PRO instruments recently developed for patients with bone metastases, clear description of instruments, and implementation of measures consistent with recommendations from instrument developers. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0941-4355
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:20
-
Issue:4
-
NIOSHTIC Number:nn:20056929
-
Citation:Support Care Cancer 2012 Apr; 20(4):657-677
-
Contact Point Address:Louis S. Matza, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
-
Email:louis.matza@unitedbiosource.com
-
Federal Fiscal Year:2012
-
Performing Organization:University of Washington
-
Peer Reviewed:True
-
Start Date:20050701
-
Source Full Name:Supportive Care in Cancer
-
End Date:20250630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:641591e5eb69a0a264497ff09110a93cdd58bf98531f16d51fd66e629cb1d6581a1ed53901e63c8cb45f1d883f977cfe1aaf68a8020fd61beab1b46de0ad08ea
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like